The demographic of mesothelioma patients has changed in recent years. Mesothelioma, a rare and deadly cancer infecting the lining of the lungs and chest cavity, is diagnosed in about 3,000 people in the United States each year. For many years, that vast majority of mesothelioma patients have been older men. Although most mesothelioma patients still […]

If you have been diagnosed with mesothelioma, a rare and deadly cancer caused by exposure to asbestos, there are numerous decisions you must make about your treatment. Although discussions with your care team may revolve around what treatment methods are best for you, a recent study shows that where you get your care may be […]

Exposure to asbestos causes a number of deadly conditions, including mesothelioma, a rare and deadly cancer infecting the lining of the lungs and chest cavity. When asbestos fibers are inhaled or ingested, they can become lodged in the chest cavity and damage the surrounding tissue, eventually leading to tumor development. Asbestos is used for many […]

Asbestos is a known carcinogen, causing a number of deadly respiratory conditions including mesothelioma. Asbestos was used widely for a number of commercial purposes throughout much of the 20th century, and although its use has been heavily restricted, it could still be lurking in many places, putting people at risk for exposure. There is no […]

Mesothelioma is rare compared with other cancers; about 2,500 to 3,000 people are diagnosed each year in the United States. The diagnosis can surprise many patients, as the disease can take up to 50 years to develop after exposure to asbestos. Mesothelioma can be a difficult journey, with painful symptoms and a short life expectancy. […]

Many people have heard of mesothelioma, but few people know what it is. Mesothelioma is a very rare cancer, infecting about 2,500 to 3,000 people in the United States each year. Lack of awareness around the disease can make it difficult to get an accurate diagnosis, which in turn can make it difficult to effectively […]

A new immunotherapy treatment may help patients with mesothelioma survive longer. Mesothelioma is a rare and aggressive cancer infecting the lining of the lungs and chest cavity, which is caused by exposure to asbestos. The disease is notoriously difficult to treat and often leaves patients with a short life expectancy. Clinical trials of an immunotherapy […]

A new immunotherapy treatment may be on the way for those suffering from mesothelioma. Patients in a Phase 1 trial for a novel T-cell therapy showed promising results, including tumor regression, and the treatment will now move into Phase 2. Mesothelioma, a rare and deadly cancer caused by asbestos exposure, is notoriously difficult to treat; […]

Mesothelioma, a rare cancer caused by asbestos exposure, is notoriously difficult to treat effectively using standard cancer therapies. Some of the most significant breakthroughs in mesothelioma treatment have been repurposing drug regimens that have proven effective in treating other diseases. Researchers are exploring the possibility of using a malaria drug to combat tumor formation in […]

Like most cancers, first-line treatment for mesothelioma often includes chemotherapy, surgery, radiation, or a combination of those treatments. Mesothelioma is very rare, however, affecting approximately 3,000 people in the United States each year; consequently, data on the effectiveness of treatment protocols is limited. A comprehensive Japanese study recently closed some of this gap by measuring […]